Valneva

Valneva FCF Margin

The Free Cash Flow Margin of Valneva (VLA.PA) as of Sep 16, 2026 is -32.85 %. In the previous year, Free Cash Flow Margin was -49.34 % — a change of -33.42% (higher).

FCF Margin

-32.85 %

YoY

-33.42%

Last updated:

Free Cash Flow Margin of Valneva is 2026 -32.85 % . Free Cash Flow Margin of Valneva was 2025 -49.34 % . It decreases by -33.42% higher compared to the previous year.

The Valneva FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2018
11.62 EUR
Jan 1, 2019
-4.24 EUR
Jan 1, 2020
107.20 EUR
Jan 1, 2021
-4.67 EUR
Jan 1, 2022
-76.02 EUR
Jan 1, 2023
-141.16 EUR
Jan 1, 2024
-49.34 EUR
Jan 1, 2025
-32.85 EUR
The Valneva FCF Margin history
YEARFCF MarginYoY
-32.85 %-33.42%
-49.34 %-65.05%
-141.16 %+85.68%
-76.02 %+1,526.41%
-4.67 %-104.36%
107.20 %-2,626.34%
-4.24 %-136.52%
11.62 %+39.18%
8.35 %+178.20%
3.00 %-108.72%
-34.43 %-31.95%
-50.60 %
Access this data via the Eulerpool API

Valneva Stock analysis

What does Valneva do? Valneva SE is a biopharmaceutical company specializing in the development, production, and marketing of vaccines for humans and animals. The company was founded in 2013 through the merger of French biotech company Vivalis and Austrian biotech company Intercell. Valneva focuses on developing vaccines for infectious diseases with a significant global burden but limited commercial demand. They work closely with governments and international organizations to improve access to their vaccines in developing countries. Valneva also has a strong presence in the animal vaccine market, producing vaccines for diseases in livestock and pets. They have developed and marketed several vaccines, including Ixiaro for Japanese encephalitis and VLA15, a vaccine candidate for Lyme disease. Overall, Valneva is an international company with an impressive pipeline of vaccine candidates and a commitment to addressing global health needs. Valneva is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valneva stock

Free Cash Flow Margin of Valneva is -32.85 % in 2026.

Free Cash Flow Margin of Valneva changed from -49.34 % to -32.85 %, representing a -33.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Valneva since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Valneva with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Valneva

All Key Metrics — Valneva